Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- 2019-nCoV Vaccine mRNA-1273 1
- Ad26COVS1 1
- Adolescent 9
- Adult 18
- Advisory Committees 1
- Age 1
- Aged 8
- Aged, 80 and over 1
- Age Factors 1
- Antigens, Bacterial 1
- Antiviral Agents 1
- Arrhythmias, Cardiac 1
- Article 4
- Articles 1
- Asian 2
- BetacoronaVirus 1
- Black People 1
- BNT162 Vaccine 1
- BNT162 Vaccine / Adverse Effects 1
- Canada 1
- Centers for Disease Control and Prevention, U.S. 2
- Child 4
- Child, Preschool 1
- Chronic Disease 1
- Community-Acquired Infections 2
- Community Health 1
- Community Health Services 1
- CoronaVirus Infections 3
- CoronaVirus Infections/Complications 1
- Cost-Benefit Analysis 2
- COVID-19 7
- COVID-19 Testing 1
- COVID-19 Vaccines 3
- COVID-19/Complications 3
- Critical Care 1
- Cross Infection 1
- Databases, Factual 3
- Death 1
- Diabetes Mellitus 1
- Diphtheria 1
- Diphtheria-Tetanus-Pertussis Vaccine 1
- Disease Management 1
- Disease Outbreaks 2
- Double-Blind Method 1
- Drinking Water 1
- Electronic Health Record 1
- Electronic Health Records 1
- Emigrants and Immigrants 2
- Ethnic Disparities 1
- Fasciitis, Necrotizing 1
- Female 11
- Full Report 1
- Health Care Surveys 2
- Hematology 1
- Hepatitis 1
- Hepatitis A 1
- Hepatitis A Vaccines 1
- Hepatitis B 9
- Hepatitis B, Chronic 5
- Hepatitis B / prevention & Control 1
- Hepatitis B Surface Antigens 4
- Hepatitis B Vaccines 3
- Hepatitis B Vaccines 1
- Hepatitis B virus 5
- Hepatitis B Virus 1
- Hepatitis C 2
- HIV Infections / epidemiology 1
- Hospitalization 3
- Humans 22
- Immunization Schedule 1
- Immunocompromised Host 1
- Immunologic Tests 1
- Incidence 2
- Indians, North American 1
- Infant 1
- Infectious Disease Transmission, Vertical 1
- Influenza, Human 1
- Influenza Vaccines 1
- Insurance Claim Review 1
- Laboratories 1
- Legionella pneumophila 1
- Legionnaires' Disease 1
- Letters To The Editor 1
- Liver Cirrhosis 1
- Male 10
- Mass Screening 4
- Middle Aged 8
- Myocarditis 4
- Pandemics 2
- Pericarditis 2
- Pneumococcal Vaccines 2
- Pneumonia, Pneumococcal 2
- Recommendations and Reports 2
- Risk Assessment 2
- Risk Factors 3
- RNA, Messenger 2
- SARS-CoV-2 6
- United States 5
- Vaccination 8
- Young Adult 7
Personal Author
Corporate Author
- CDC COVID-19 Emergency Response Team. 3
- CDC COVID-19 Response Team. 1
- Center for Child Health, Behavior and Development, Seattle Children’s Research Institute, Seattle Children’s Hospital, Seattle, Washington 1
- Centers for Disease Control and Prevention (U.S.) 2
- Children’s Healthcare of Atlanta. 2
- Children’s Hospital of Philadelphia. Applied Clinical Research Center. Department of Pediatrics. 1
- Div. of Bacterial Diseases 1
- Div. of Global Migration and Quarantine 1
- Div. of Viral Diseases 1
- Div. of Viral Hepatitis 1
- Emory University School of Medicine. 1
- Fenway Institute. 1
- GAP Solutions, Inc. 2
- Harvard Pilgrim Health Care Institute. Department of Population Medicine. 1
- Immunization Services Div. 1
- Influenza Div. 1
- Leidos Inc. 1
- Lewis Katz School of Medicine. Department of Medicine. 1
- Louisiana Public Health Institute. 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.) 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. 2
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) 3
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis. 2
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)Division of Viral Hepatitis. 1
- National Center for Immunization and Respiratory Diseases (U.S.) 1
- National Patient-Centered Clinical Research Network. 1
- Nemours Children’s Health System. Nemours Cardiac Center. 1
- OCHIN, Inc. 1
- Stanford University School of Medicine. Department of Pediatrics. 1
- United States. Advisory Committee on Immunization Practices. 3
- University of Arkansas for Medical Sciences. Department of Pediatrics. Section of Pediatric Infectious Diseases. 1
- University of North Carolina at Chapel Hill. School of Medicine. Center for Gastrointestinal Biology and Disease. 1
- University of Texas Southwestern Medical Center at Dallas. Department of Population and Data Sciences and Department of Immunology. 1
- Vanderbilt School of Medicine. Department of Health Policy. 1
Place as Subject
- Alabama 1
- Arizona 1
- Chicago, IL 1
- Colorado 1
- Florida 1
- Iowa 1
- Kansas 1
- Kenya 1
- Louisiana 1
- Maryland 1
- Michigan 1
- Missouri 1
- Nebraska 1
- New York 1
- North Carolina 1
- Ohio 1
- Pennsylvania 1
- South Carolina 1
- Tennessee 1
- Texas 1
- U.S. 2
- United States 13
- Utah 1
- Wisconsin 1
Resource Type General
Resource Type Specific
Keywords
- adult 1
- Adults 1
- Antiviral Agents 1
- booster dose 1
- Chlorination 1
- Cost-effectiveness 1
- coverage 1
- COVID-19 1
- diabetes mellitus 1
- Hepatitis A 1
- Hepatitis B vaccine 1
- Household water treatment 1
- Humans 1
- J&J 1
- National Health Interview Survey (NHIS) 1
- Safe water storage 1
- SARS-CoV-2 vaccine effectiveness 1
- trends 1
- vaccination 1
- Vaccines 1
Select all docs (Max 200)
1 -
20 of 32 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- 2019-nCoV Vaccine mRNA-1273 (1)
- Ad26COVS1 (1)
- Adolescent (9)
- Adult (18)
- Advisory Committees (1)
- Age (1)
- Aged (8)
- Aged, 80 and over (1)
- Age Factors (1)
- Antigens, Bacterial (1)
- Antiviral Agents (1)
- Arrhythmias, Cardiac (1)
- Article (4)
- Articles (1)
- Asian (2)
- BetacoronaVirus (1)
- Black People (1)
- BNT162 Vaccine (1)
- BNT162 Vaccine / Adverse Effects (1)
- Canada (1)
- Centers for Disease Control and Prevention, U.S. (2)
- Child (4)
- Child, Preschool (1)
- Chronic Disease (1)
- Community-Acquired Infections (2)
- Community Health (1)
- Community Health Services (1)
- CoronaVirus Infections (3)
- CoronaVirus Infections/Complications (1)
- Cost-Benefit Analysis (2)
- COVID-19 (7)
- COVID-19 Testing (1)
- COVID-19 Vaccines (3)
- COVID-19/Complications (3)
- Critical Care (1)
- Cross Infection (1)
- Databases, Factual (3)
- Death (1)
- Diabetes Mellitus (1)
- Diphtheria (1)
- Diphtheria-Tetanus-Pertussis Vaccine (1)
- Disease Management (1)
- Disease Outbreaks (2)
- Double-Blind Method (1)
- Drinking Water (1)
- Electronic Health Record (1)
- Electronic Health Records (1)
- Emigrants and Immigrants (2)
- Ethnic Disparities (1)
- Fasciitis, Necrotizing (1)
- Female (11)
- Full Report (1)
- Health Care Surveys (2)
- Hematology (1)
- Hepatitis (1)
- Hepatitis A (1)
- Hepatitis A Vaccines (1)
- Hepatitis B (9)
- Hepatitis B, Chronic (5)
- Hepatitis B / prevention & Control (1)
- Hepatitis B Surface Antigens (4)
- Hepatitis B Vaccines (3)
- Hepatitis B Vaccines (1)
- Hepatitis B virus (5)
- Hepatitis B Virus (1)
- Hepatitis C (2)
- HIV Infections / epidemiology (1)
- Hospitalization (3)
- Humans (22)
- Immunization Schedule (1)
- Immunocompromised Host (1)
- Immunologic Tests (1)
- Incidence (2)
- Indians, North American (1)
- Infant (1)
- Infectious Disease Transmission, Vertical (1)
- Influenza, Human (1)
- Influenza Vaccines (1)
- Insurance Claim Review (1)
- Laboratories (1)
- Legionella pneumophila (1)
- Legionnaires' Disease (1)
- Letters To The Editor (1)
- Liver Cirrhosis (1)
- Male (10)
- Mass Screening (4)
- Middle Aged (8)
- Myocarditis (4)
- Pandemics (2)
- Pericarditis (2)
- Pneumococcal Vaccines (2)
- Pneumonia, Pneumococcal (2)
- Recommendations and Reports (2)
- Risk Assessment (2)
- Risk Factors (3)
- RNA, Messenger (2)
- SARS-CoV-2 (6)
- United States (5)
- Vaccination (8)
- Young Adult (7)
- CDC COVID-19 Emergency Response Team. (3)
- CDC COVID-19 Response Team. (1)
- Center for Child Health, Behavior and Development, Seattle Children’s Research Institute, Seattle Children’s Hospital, Seattle, Washington (1)
- Centers for Disease Control and Prevention (U.S.) (2)
- Children’s Healthcare of Atlanta. (2)
- Children’s Hospital of Philadelphia. Applied Clinical Research Center. Department of Pediatrics. (1)
- Div. of Bacterial Diseases (1)
- Div. of Global Migration and Quarantine (1)
- Div. of Viral Diseases (1)
- Div. of Viral Hepatitis (1)
- Emory University School of Medicine. (1)
- Fenway Institute. (1)
- GAP Solutions, Inc. (2)
- Harvard Pilgrim Health Care Institute. Department of Population Medicine. (1)
- Immunization Services Div. (1)
- Influenza Div. (1)
- Leidos Inc. (1)
- Lewis Katz School of Medicine. Department of Medicine. (1)
- Louisiana Public Health Institute. (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.) (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. (2)
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) (3)
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis. (2)
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)Division of Viral Hepatitis. (1)
- National Center for Immunization and Respiratory Diseases (U.S.) (1)
- National Patient-Centered Clinical Research Network. (1)
- Nemours Children’s Health System. Nemours Cardiac Center. (1)
- OCHIN, Inc. (1)
- Stanford University School of Medicine. Department of Pediatrics. (1)
- United States. Advisory Committee on Immunization Practices. (3)
- University of Arkansas for Medical Sciences. Department of Pediatrics. Section of Pediatric Infectious Diseases. (1)
- University of North Carolina at Chapel Hill. School of Medicine. Center for Gastrointestinal Biology and Disease. (1)
- University of Texas Southwestern Medical Center at Dallas. Department of Population and Data Sciences and Department of Immunology. (1)
- Vanderbilt School of Medicine. Department of Health Policy. (1)
- Alabama (1)
- Arizona (1)
- Chicago, IL (1)
- Colorado (1)
- Florida (1)
- Iowa (1)
- Kansas (1)
- Kenya (1)
- Louisiana (1)
- Maryland (1)
- Michigan (1)
- Missouri (1)
- Nebraska (1)
- New York (1)
- North Carolina (1)
- Ohio (1)
- Pennsylvania (1)
- South Carolina (1)
- Tennessee (1)
- Texas (1)
- U.S. (2)
- United States (13)
- Utah (1)
- Wisconsin (1)
- adult (1)
- Adults (1)
- Antiviral Agents (1)
- booster dose (1)
- Chlorination (1)
- Cost-effectiveness (1)
- coverage (1)
- COVID-19 (1)
- diabetes mellitus (1)
- Hepatitis A (1)
- Hepatitis B vaccine (1)
- Household water treatment (1)
- Humans (1)
- J&J (1)
- National Health Interview Survey (NHIS) (1)
- Safe water storage (1)
- SARS-CoV-2 vaccine effectiveness (1)
- trends (1)
- vaccination (1)
- Vaccines (1)
- :Francois Watkins, Louise K. ;Toews, Karrie-Ann E.Dec 06 2016 | Infect Control Hosp Epidemiol. 38(3):306-313.:OBJECTIVESTo define the scope of an outbreak of Legionnaires’ disease (LD), to identify the source, and to stop transmission.DESIGN AND SETTINGEpide...
- :Marseille, Elliot ;Harris, Aaron M.7 2021 | Sex Health. 18(3):269-279:Background.Hepatitis B vaccination is recommended for persons with current or past sexually transmitted infections (STI). Our aim is to systematically...
- :Harris, Aaron M. ;Beekmann, Susan E.May 17 2014 | Diagn Microbiol Infect Dis. 79(4):454-457.:Streptococcus pneumoniae (pneumococcus) is the most common bacterial etiology of community-acquired pneumonia (CAP) in adults, a leading cause of deat...
- :Wang, Timothy ;Liu, YuApril 2020 | J Community Health. 45(2):412-418:Background:Chronic hepatitis B (CHB) disproportionately affects non-US born Asians. The Hmong have been shown to have the highest rates of CHB and mor...
- :Weng, Mark K. ;Harris, Aaron M.1 26 2021 | JAMA. 325(4):401
- :Harris, Aaron M. ;Yazzie, DelJan 2015 | Emerg Infect Dis. 21(1):177-179.
- :Harris, Aaron M. ;Isenhour, CherylApr 01 2018 | Infect Dis Obstet Gynecol. 2018; 2018.:IntroductionPregnant women should receive hepatitis B virus (HBV) testing with hepatitis B surface antigen (HBsAg), but it is unclear whether HBV-infe...
- :Harris, Aaron M.03/23/2018 | ACIP meeting Hepatitis Vaccines:Presentations February 2018 Day 1Publication date from document properties.Hepatitis-02-Harris-508.pdf
- :Hutton, David ;Toy, Mehlika7 2022 | Sex Transm Dis. 49(7):517-525:Background.The estimated number of people living with hepatitis B virus (HBV) infection acquired through sexual transmission was 103,000 in 2018, with...
- :Roberts, Henry ;Jiles, Ruth4 01 2021 | Sex Transm Dis. 48(4):305-309:Background:Sexual transmission of hepatitis B virus (HBV) is common in the United States. In 2008, an estimated 50% of HBV infections were attributed ...
- :Chak, Eric ;Taefi, AmirAugust 08 2018 | Cancer Epidemiol Biomarkers Prev. 27(11):1352-1357:Background:Implementation of screening recommendations for chronic hepatitis B (CHB) among foreign-born persons at risk has been sub-optimal. The use ...
- :Lu, Peng-jun ;Hung, Mei-Chuan11 2021 | Am J Prev Med. 61(5):652-664:Background:Hepatitis B vaccination is routinely recommended for adults with diabetes mellitus (DM) aged <60 years and for those aged ≥60 years at th...
- :Kompaniyets, Lyudmyla ;Wiegand, Ryan E.5 24 2023 | Clin Infect Dis. 76(10):1753-1760:Background.Small sample sizes have limited prior studies’ ability to capture severe COVID-19 outcomes, especially among Ad26.COV2.S vaccine recipien...
- :Kobayashi, Miwako ;Bigogo, Godfrey04/09/2019:Kenya introduced 10-valent pneumococcal conjugate vaccine (PCV10) among children <1 year in 2011 with catch-up vaccination among children 1–4 years ...
- :Leidner, Andrew J. ;Murthy, Neil1 07 2019 | Vaccine. 37(2):226-234:Background:Coverage levels for many recommended adult vaccinations are low. The cost-effectiveness research literature on adult vaccinations has not b...
- :Block, Jason P. ;Boehmer, Tegan K.4 08 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Cardiac Complications, particularly myocarditis and pericarditis, have been associated with SARS-CoV-2 (the Virus that causes COVID-19) infection (1-3...
- :Harris, Aaron M. ;Link-Gelles, RuthMay 18 2018 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Among an estimated 850,000 to 2.2 million persons with chronic hepatitis B Virus (HBV) infection in the United States, 70% are non-U.S.-born (1,2). Al...
- :Bennett, Nancy M. ;Pilishvili, TamaraJun 28 2013 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):On February 20, 2013, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal conjugate vaccine (PCV...
- :Boehmer, Tegan K. ;Kompaniyets, Lyudmyla9 03 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Viral infections are a common cause of myocarditis, an inflammation of the heart muscle (myocardium) that can result in hospitalization, heart failure...
- :Yek, Christina ;Warner, Sarah1 07 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Vaccination against SARS-CoV-2, the Virus that causes COVID-19, is highly effective at preventing COVID-19-associated hospitalization and death; howev...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.